New rankings in the Life Science Investment Hotlist for the Stockholm-Uppsala region

The internationally acclaimed list of fast growing companies is expanding. The original 20 companies have now become 40, and a new ranking has been done for the ten companies in the greatest demand. Digital health is the area on the list with the largest increase.

The list has been updated with the top ten companies that are seeing the greatest demand from Investors right now.

“A whole lot is happening now in the field of life science in the Stockholm-Uppsala region, and that is why we updated the list,” observes Ylva Hultman Erlandsson, Business Development Manager at Stockholm Business Region Development.

One company within the digital health field is DDinnovation AB. They have developed an app that will help patients in rural areas to more quickly obtain a diagnosis and information on whether they need to go to the hospital.

There are also more companies in the Stockholm-Uppsala region doing research on stem cells. Two companies that can be mentioned in this regard is IsletOne Therapeutics and Biolamina AB.

“The interest in stem cells research is substantial in the region, and we are internationally successful. Kenneth Chien is one example of this. Kenneth left Harvard to conduct research at the Karolinska Institute in Stockholm,” notes Ylva Hultman Erlandsson.

The Life Science Investment Hotlist functions as a tool for investors, and by creating awareness of companies, joint projects and other collaborations are fostered. To qualify for the list, the company must offer a product or service with a global potential.

See the Investment Hotlist in its entirety:
www.investstockholm.com/en/Life-Science-Hotlist